Accurate activity measurements of radionuclides using commercial dose calib
rators requires that the correct dial setting (or calibration factor) be ap
plied. The dose calibrator setting for the medical radionuclide Re-188 (as
(ReO4-)-Re-188) has been determined experimentally using solution sources p
repared and calibrated at the National Institute of Standards and Technolog
y (NIST). Methods: The specific activity of two sources (in units of MBq/g)
in the standard 5-mL NIST ampoule and in a 5-mL SoloPak dose vial were cal
ibrated using 4 pi beta liquid scintillation counting with H-3-standard eff
iciency tracing and gamma-ray/bremmstrahlung counting in the NIST "4 pi" ga
mma ionization chamber on gravimetrically related sources. Results: The new
ly determined settings for the NIST Capintec CRC-12 dose calibrator are (63
1 +/- 4) x 10 and (621 +/- 3) x 10 for the respective ampoule and dose vial
geometries with an expanded (at a presumed 95% confidence level) uncertain
ty of 0.4%-0.5% in the activity determination. The setting for the dose via
l geometry was independently confirmed using a Capintec CRC-15R at Cedars-S
inai Medical Center using sources calibrated against a NIST standard. Concl
usion: These new settings result in activity readings 28%-30% lower than th
ose obtained using the previously recommended setting of 496 x 10. This dis
crepancy most likely results from underestimating the total radiation yield
from Re-188 decay when calculating the dose calibrator response. This stud
y emphasizes the need for experimental determinations of dose calibrator se
ttings in the geometry in which the measurements will be performed.